Dissertation > Excellent graduate degree dissertation topics show

Glucocorticoid treatment clinical study of the acute phase of idiopathic facial paralysis

Author: ZouNa
Tutor: WangPengQin
School: Liaoning University of Traditional Chinese Medicine
Course: Traditional Chinese Medicine
Keywords: diopathic facial palsy the acute phase glucocorticoid
CLC: R745.12
Type: Master's thesis
Year: 2011
Downloads: 15
Quote: 0
Read: Download Dissertation

Abstract


Purpose: By observing glucocorticoid in the treatment of acute idiopathic facial palsy, to guide clinical practices, treatment of the disease.Methods: Take randomized method to collect the patients who were first diagnosed with idiopathic facial palsy .Randomly divided into three groups. Group A with 54 patients and Group B with 33 patients were treated with glucocorticoid .Group C with 31 patients were treated with non-glucocorticoid. Three groups were all treated with Vitamin B1, mecobalamin tablets, TDP and acupuncture, the patients who had virus were given Aciclovir Dispersible Tablets. The patients of Group A were given Prednisone Acetate Tablets ,usage for: dose 30mg/d, one times perday continuous oral 5 days, then in 7 to 10 days, and gradually reduction to withdrawal .The patients of Group B were given Prednisone Acetate Tablets ,usage for: dose 20mg/d, one times perday continuous oral 5 days, then in 7 to 10 days, and gradually reduction to withdrawal . Three groups were continuous treated for 30 days. The results of three groups were evaluated according to Portmann’s Simple Scale.Result: After treatment,the score of Group A was 19.24±0.845,Group B was 19.17±0.937,Group C was 11.87±6.015. Score of the function of facial muscles obtained from both Group A and Group B were distinctly higher than that from Group C,as well as the improvement index(P~c﹤0.05,P~b﹤0.05),the score and the improvement index of Group A and Group B were nearly the same(P~a﹥0.05).Group A: cure rate was 72.2%, markedly effective rate was 18.5%, improved was 9.3%, invalid 0, the effective rate was 90.7%; Group B: cure rate was 72.7%,markedly effective rate was 18.2%,improved 9.1%,invalid 0,the effective rate was 90.9%;Group C: cure rate was 48.4%, markedly effective rate was 16.1%, improved was 29.0 %, 6.5% is not valid, the effective rate was 64.5%.The effective rate of Group A and Group B were higher than that of Group C (~cP﹤0.05,~bP﹤0.05),the effective rate of Group A and Group B were nearly the same(~aP﹥0.05). Conclusion:1 Treatment of acute idiopathic facial palsy with glucocorticoid improve the efficacy.2 Glucocorticoid is one of conventional treatment of acute diopathic facial palsy , when patients with no clinical contraindications, the clinical application of glucocorticoids is necessary ,to achieve clinical practices, treatment of the disease.3 In the treatment of acute idiopathic facial palsy, the use of glucocorticoids can reduce the dosage, optimizing therapies.

Related Dissertations

  1. A Stuty on the Diversification of Interleukin-17 of Asthma Mouse and the Affection of the Treament of Glucocorticoids,R562.25
  2. Retrospective Study of Asthmatic Children Received Inhaled Corticosteroid Therapy,R725.6
  3. Expression of GRα、 GRβ on PBMC and Kidney Tissues of Patients with Primary Nephrotic Syndrome,R726.91
  4. The Change and Significance of CD4~+ CD25~+ T Regulatory Cells in Children with Primary Nephritic Syndrome,R726.91
  5. The Effects of Rosiglitazone and Prednisone on the Expression of FIZZ1 in the Pulmonary Fibrosis Induced by Blemycin,R965
  6. Clinical Research on Integrated Treatment of TCM and Western Medicine to Acute Period of Ischemic Stroke,R743.3
  7. Clinical Analysis of 60 Cases of Bullous Pemphigoid,R758.66
  8. Retrospective Study on the Predictive Value of Th1/Th2 Cytokines in Pediatric Hematology-oncology Patients with Sepsis for the Severity and Treatment,R720.597
  9. The Relationship between MicroRNA-182 and Glucocorticoids-resistance in Lymphoblastic Malignancies,R392.4
  10. Cupping therapy clinical study of peripheral facial paralysis,R246
  11. The Different Expression of Survivin Gene in GC-sensitive and GC-resistant Leukemia Cell Line and Its Clinical Significance,R733.7
  12. Analysis of Th17 Cells and Regulatory T Cells in Myasthenia Gravis,R746.1
  13. Peroxisome proliferator-activated receptor γ and steroid receptor interactions in,R587.1
  14. Effects of A-SAA on the Expressions of Inflammatory Cytokines mRNA , Protein and Related Kinases of 3T3-L1 Adipocytes,R587.1
  15. BCG-PSN Down-regulates IL-17 of CD4~+T Lymphocytes in Mice with Acute Asthma.,R562.25
  16. Expression and Activation of NF-κBp65 in Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus,R593.241
  17. Dracorhodin Perchlorate Can Inhibit High Glucose Active TGF-β1/SGK1/FN Signal Pathway in Human Mesangial Cells,R285
  18. Effect of Moxibustion on the GC Signal Pathway in Synoviocyte of Experimental RA,R245
  19. Changes of GR and SR-1A in Cochlear Nucleus and Hearing Impairment in Prenatal Stress Rat Offsprings,R764
  20. Therapeutic effects of different doses of methylprednisolone intreating EAE and correlation study on efficacy, glucocorticoidreceptor isoforms and SRp30c,R744.51

CLC: > Medicine, health > Neurology and psychiatry > Neurology > Peripheral nerves and ganglia disease > Brain disease > Facial nerve disease
© 2012 www.DissertationTopic.Net  Mobile